Mathrubhumi EnglishMar 12
Medicine prices in India may rise 10–20% by March-end as Strait of Hormuz disruptions push up fuel, logistics and pharma manufacturing costs. https://english.mathrubhumi.com/news/money/india-pharma-price-hike-west-asia-crisis-x0wrpidp?utm_source=dlvr.it&utm_medium=mastodon #MedicinePrices #PharmaIndustry #IndiaPharma #HormuzCrisis
Mathrubhumi EnglishDec 3
India`s PLI schemes are driving significant investment and production in Active Pharmaceutical Ingredient (API) manufacturing, reducing import dependence and enhancing drug security. https://english.mathrubhumi.com/news/india/india-api-manufacturing-pli-scheme-sstgtych?utm_source=dlvr.it&utm_medium=mastodon #IndiaPharma #APImanufacturing #PLIScheme #BulkDrugPark
Mathrubhumi EnglishAug 28, 2025
From “Pharmacy of the World” to “Intelligent Pharmacy of the World” — India’s AI-driven pharma revolution is rewriting the future of global medicine https://english.mathrubhumi.com/news/india/how-ai-is-turning-india-from-pharmacy-of-the-world-into-intelligent-pharmacy-of-the-world-y1zv5hi0?utm_source=dlvr.it&utm_medium=mastodon #IndiaPharma #AIinHealthcare #DrugDiscovery #PharmacyOfTheWorld
hritikasahuAug 19, 2025
India Pharma Industry leads globally in generics, driven by R&D, exports & healthcare reforms.
#IndiaPharma #HealthcareTrends #MarketInsights
🔗 Read Full Report: https://www.kenresearch.com/india-pharmaceuticals-industry-market?utm_source=mastodon&utm_medium=Referral&utm_campaign=Hritika
India Pharmaceuticals Market | 2019 – 2030 | Ken Research

India pharmaceuticals market valued at USD 61 billion, driven by generics demand, chronic diseases, and exports to 200 countries. Growth fueled by biotech and healthcare spending.